Aktuellt
SENASTE
At SEB’s Nordic Seminar, Bactiguard’s CEO, Anders Göransson, provided an upbeat presentation about Bactiguard’s opportunities. Our take is that whilst C-19 uncertainty is still lingering, over recent years, via reaching new partnerships (e.g. trauma implants) and the strategic acquisition of Vigilenz (e.g. wound care), Bactiguard has added further to its platform and thus also to the growth potential of the company.
LÄS MER
